137 results on '"Selaru, Florin M."'
Search Results
2. Patient-derived functional organoids as a personalized approach for drug screening against hepatobiliary cancers
3. Untethered shape-changing devices in the gastrointestinal tract
4. PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease
5. Extracellular Vesicles in Hepatocellular Carcinoma: Progress and Challenges in the Translation from the Laboratory to Clinic
6. Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
7. Non-Viral Gene Delivery to Hepatocellular Carcinoma via Intra-Arterial Injection
8. Supplementary Table 1 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
9. Supplementary Table 3 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
10. Supplementary Figure 2 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
11. Supplementary Figure Legends 1-2 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
12. Supplementary Table 2 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
13. Supplementary Methods section from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
14. Supplementary Methods section from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
15. Data from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
16. Data from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
17. Supplementary Figure Legends 1-2 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
18. Supplementary Figure 1 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
19. Supplementary Table 1 from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
20. Supplementary Table 2 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
21. Supplementary Table 2 from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
22. Data from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
23. Supplementary Table 3 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
24. Supplementary Table 2 from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
25. Supplementary Figure 1 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
26. Supplementary Table 1 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
27. Supplementary Table 1 from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
28. Supplementary Figure 2 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
29. Supplementary Table 4 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
30. Data from Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
31. Supplementary Table 4 from A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus
32. Use of Biologics for the Treatment of Inflammatory Conditions of the Pouch
33. A nanofiber-hydrogel composite improves tissue repair in a rat model of Crohn’s disease perianal fistulas
34. Adipokine C1q/Tumor Necrosis Factor- Related Protein 3 (CTRP3) Attenuates Intestinal Inflammation Via Sirtuin 1/NF-κB Signaling
35. A combination therapy of bortezomib, CXCR4 inhibitor and checkpoint inhibitor is effective in cholangiocarcinoma in vivo
36. Injectable, drug-eluting nanocrystals prevent fibrosis and stricture formation in vivo
37. Autonomous Untethered Microinjectors for Gastrointestinal Delivery of Insulin
38. Biostimulatory Micro‐Fragmented Nanofiber‐Hydrogel Composite Improves Mesenchymal Stem Cell Delivery and Soft Tissue Remodeling
39. Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
40. Quaternary nanoparticles enable sustained release of bortezomib for hepatocellular carcinoma
41. Adipokine C1q/Tumor necrosis factor-Related Protein 3 (CTRP3) Attenuates Intestinal Inflammation via Histone Deacetylase Sirtuin 1 (SIRT1)/NF-κB Signaling
42. Autonomous untethered microinjectors for gastrointestinal delivery of insulin
43. Sa1528: LYOPHILIZED UMBILICAL CORD TISSUE IS EFFECTIVE AS FISTULA PLUG IN A RAT MODEL OF CROHN'S PERIANAL FISTULA
44. Sa1527: A NONOFIBER-HYDROGEL SCAFFOLD EMBEDDED WITH MESENCHYMAL STEM CELLS FOR THE TREATMENT OF CROHN'S PERIANAL FISTULAS IN A RAT MODEL
45. Mo1556: INFLIXIMAB VERSUS ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN’S DISEASE
46. Sa1602: DISEASE OUTCOMES AFTER SEGMENTAL RESECTION OF COLONIC CROHN'S DISEASE: A RETROSPECTIVE MULTICENTER STUDY.
47. Sa1064: IMPACT OF COVID-19 PANDEMIC ON PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A LOCAL REPORT
48. 948: QUATERNARY COMPLEX NANOPARTICLES ENABLE TARGETED, SUSTAINED RELEASE BORTEZOMIB OF HEPATOCELLULAR CARCINOMA
49. Mo1121: ADIPOKINE C1Q/TNF-RELATED PROTEIN 3 (CTRP3) SUPPRESSES COLONIC INFLAMMATION IN MOUSE COLITIS MODELS
50. Tu1658: ENTERAL INSULIN DELIVERED BY ANTONOMOUS MICROINJECTORS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.